Cargando…
Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors
Adoptive cell transfer (ACT) is an emerging anticancer therapy that has shown promise in various malignancies. Redirecting antigen specificity by genetically engineering T cells to stably express receptors has become an effective variant of ACT. A novel extension of this approach is to utilize engin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910704/ https://www.ncbi.nlm.nih.gov/pubmed/27467930 http://dx.doi.org/10.1080/2162402X.2015.1122158 |